ICAM1 and skin basal cell carcinoma: Our study investigated the expression of several immune-related biomarkers (i.e., CD3ε, CD25, CD68, ICAM-1, IFN-γ, and IL-10) in the peri-tumoral milieu of BCC tumors and their relationship to the appearance of subsequent new BCCs.